Patents by Inventor Bernard Hublot

Bernard Hublot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10675266
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of autism spectrum disorders (ASD).
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: June 9, 2020
    Assignee: BIOCODEX
    Inventors: Bernard Hublot, Rene Levy, Marie-Emmanuelle Le Guern
  • Patent number: 10183008
    Abstract: Methods for terminating, preventing, and/or treating status epilepticus are generally provided. The method can include administering a prophylactically or therapeutically effective amount of stiripentol or a related compound thereof to an individual in need of treatment of status epilepticus. The individual can be in need of treatment of prolonged status epilepticus, refractory status epilepticus, and/or benzodiazepine-resistant status epilepticus.
    Type: Grant
    Filed: September 19, 2012
    Date of Patent: January 22, 2019
    Assignee: University of South Carolina
    Inventors: David D. Mott, Janet L. Fisher, Rene H. Levy, Marie-Emmanuelle LeGuern, Marc Verleye, Bernard Hublot
  • Publication number: 20180325864
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of autism spectrum disorders (ASD).
    Type: Application
    Filed: July 23, 2018
    Publication date: November 15, 2018
    Inventors: Bernard HUBLOT, Rene LEVY, Marie-Emmanuelle LE GUERN
  • Patent number: 9241961
    Abstract: The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: January 26, 2016
    Assignee: BIOCEDEX
    Inventors: Philippe Girard, Marie-Emmanuelle Le Guern, Marc Verleye, Bernard Hublot
  • Patent number: 8927600
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of peripheral neuropathies.
    Type: Grant
    Filed: March 18, 2010
    Date of Patent: January 6, 2015
    Assignee: Biocodex
    Inventors: Marie-Emmanuelle Le Guern, Marc Verleye, Jean-Marie Gillardin, Bernard Hublot
  • Patent number: 8598221
    Abstract: The present invention relates to a pharmaceutical composition comprising as active substances: at least one compound of the following general formula (I): and at least one inhibitor of type 2 cyclooxygenase (COX-2), notably for use in the prevention or treatment of pain.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: December 3, 2013
    Assignee: Biocodex
    Inventors: Philippe Girard, Marie-Emmanuelle Le Guern, Jean-Marie Gillardin, Bernard Hublot
  • Patent number: 8575211
    Abstract: The present invention relates to a pharmaceutical composition comprising as active substances: at least one compound of the following general formula (I): and at least one compound of the following general formula (V): especially for its use in the prevention or treatment of pain.
    Type: Grant
    Filed: October 28, 2009
    Date of Patent: November 5, 2013
    Assignee: Biocodex
    Inventors: Philippe Girard, Marie-Emmanuelle Le Guern, Laurence Berthon-Cedille, Jean-Marie Gillardin, Bernard Hublot
  • Patent number: 8420644
    Abstract: The present invention relates to the use of at least one compound of formula (I) below: or at least one of the pharmaceutically acceptable salts thereof, for the preparation of a medicament intended for the prevention or for the treatment of cerebral edemas.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: April 16, 2013
    Assignee: Biocodex
    Inventors: Marie-Emmanuelle Le Guern, Philippe Girard, Jean-Marie Gillardin, Laurence Berthon-Cedille, Bernard Hublot
  • Patent number: 8338410
    Abstract: This invention relates to the use of at least one compound of the following formula (I): or its pharmaceutically acceptable salts, for the preparation of a medicinal compound having neuroprotective activity intended to prevent or treat neurone deteriorations.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: December 25, 2012
    Assignee: Biocodex
    Inventors: Marc Verleye, Marie-Emmanuelle Le Guern, Philippe Girard, Jean-Marie Gillardin, Laurence Berthon-Cedille, Bernard Hublot
  • Publication number: 20110136885
    Abstract: The present invention relates to a pharmaceutical composition comprising as active substances: at least one compound of the following general formula (I): and at least one inhibitor of type 2 cyclooxygenase (COX-2), notably for use in the prevention or treatment of pain.
    Type: Application
    Filed: December 3, 2010
    Publication date: June 9, 2011
    Inventors: Philippe GIRARD, Marie-Emmanuelle Le Guern, Jean-Marie Gillardin, Bernard Hublot
  • Publication number: 20110135616
    Abstract: The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.
    Type: Application
    Filed: December 7, 2010
    Publication date: June 9, 2011
    Inventors: Philippe GIRARD, Marie-Emmanuelle Le Guern, Marc Verleye, Bernard Hublot
  • Publication number: 20100240588
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of peripheral neuropathies.
    Type: Application
    Filed: March 18, 2010
    Publication date: September 23, 2010
    Inventors: Marie-Emmanuelle LE GUERN, Marc Verleye, Jean-Marie Gillardin, Bernard Hublot
  • Patent number: 7799328
    Abstract: The present invention relates to a method of treating or preventing weight loss of patients with inflammatory bowel diseases comprising administering to said patients an effective amount of Saccharomyces boulardii.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: September 21, 2010
    Assignee: Biocodex
    Inventors: Bernard Hublot, Herve Groux, Rene Levy, Marie-Emmanuelle Le Guern, Paul Bernasconi
  • Publication number: 20100197777
    Abstract: The present invention relates to a pharmaceutical composition comprising as active substances: at least one compound of the following general formula (I): and at least one compound of the following general formula (V): especially for its use in the prevention or treatment of pain.
    Type: Application
    Filed: October 28, 2009
    Publication date: August 5, 2010
    Inventors: Philippe GIRARD, Marie-Emmanuelle Le Guern, Laurence Berthon-Cedille, Jean-Marie Gillardin, Bernard Hublot
  • Patent number: 7750169
    Abstract: The invention relates to a process for the preparation of stiripentol particles having a defined particle size distribution.
    Type: Grant
    Filed: January 22, 2009
    Date of Patent: July 6, 2010
    Assignee: Biocodex
    Inventors: Bernard Hublot, Laurence Berthon-Cedille, Marie-Emmanuelle Leguern, Gilles Renaud
  • Publication number: 20100144863
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of autism spectrum disorders (ASD).
    Type: Application
    Filed: December 9, 2009
    Publication date: June 10, 2010
    Inventors: Bernard HUBLOT, René Levy, Marie-Emmanuelle Le Guern
  • Publication number: 20090298817
    Abstract: The present invention relates to the use of at least one compound of formula (I) as follows: or of at least one pharmaceutically acceptable salt thereof for the preparation of a drug for the prevention or treatment of memory disorders.
    Type: Application
    Filed: May 6, 2009
    Publication date: December 3, 2009
    Inventors: Marc Verleye, Marie-Emmanuelle Le Guern, Jean-Marie Gillardin, Bernard Hublot
  • Patent number: 7569565
    Abstract: The present invention relates to the use of at least one compound of formula (I) below: or of its pharmaceutically acceptable salts, in the preparation of a medicament for the prevention or treatment of cerebral oedemas.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: August 4, 2009
    Assignee: Biocodex
    Inventors: Marie-Emmanuelle Le Guern, Philippe Girard, Jean-Marie Gillardin, Laurence Berthon-Cedille, Bernard Hublot
  • Publication number: 20090187034
    Abstract: The invention relates to a process for the preparation of stiripentol particles having a defined particle size distribution.
    Type: Application
    Filed: January 22, 2009
    Publication date: July 23, 2009
    Inventors: Bernard HUBLOT, Laurence BERTHON-CEDILLE, Marie-Emmanuelle LEGUERN, Gilles RENAUD
  • Publication number: 20070167446
    Abstract: This invention relates to the use of at least one compound of the following formula (I): or its pharmaceutically acceptable salts, for the preparation of a medicinal compound having neuroprotective activity intended to prevent or treat neurone deteriorations.
    Type: Application
    Filed: July 18, 2006
    Publication date: July 19, 2007
    Inventors: Marc Verleye, Marie-Emmanuelle Le Guern, Philippe Girard, Jean-Marie Gillardin, Laurence Berthon-Cedille, Bernard Hublot